SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (143)7/24/1998 3:20:00 AM
From: John Dwyer   of 359
 
This is a good point. However, the bulk of the increase in
spending occurred in the screening systems and R&D categories...
this further highlights my concern a couple months ago that
the UHTSS is going to begin consuming a tremendous amount of
cash. The screening collaborations do not provide enough cash
flow to help offset these expenditures and they will not
receive milestone payments until they deliver the microfluidics
modules. Let's hope that they somehow deliver these on time... ABSC
does not want to float a secondary in the current biotech market.

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext